Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03416010 · ClinicalTrials.gov registry record · NA
Healthy Lifestyle Intervention for High-Risk Minority Pregnant Women
A NA study of Depression and Anxiety, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 299
- Enrollment target
- 3
- Study locations
NCT03416010: Completed NA study of Depression and Anxiety, sponsored by Ohio State University.
NCT03416010 is a NA study of Depression and Anxiety that has completed, run by Ohio State University. The registered enrollment target is 299 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (62% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03416010, a NA study of Depression and Anxiety, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 299 participants
- Enrollment target
- 3
- Study locations
Study Summary
The overall purpose of this application is to evaluate the efficacy of an intervention designed to decrease health disparities in pregnant, emotionally distressed, minority women. This randomized controlled trial will test a six session (spaced over 18 weeks) cognitive behavioral skills building (CBSB) prenatal care intervention (specifically designed and based on prior research for pregnant minority women experiencing emotional distress) at three sites (Jacobi Medical Center, New York City and The Ohio State University Total Health and Wellness Clinic, and The Ohio State University Wexner Medical Center OB/GYN Columbus, Ohio.
Primary Outcome
Healthy Lifestyle Beliefs Scale survey will be administered at each of the in-person meetings. This scale taps beliefs about various facets of maintaining a healthy lifestyle. This 16-item is scored on a five point Likert-type scale that ranging from 1 strongly disagree to 5 strongly agree. The minimum score is 16 and the maximum score is 80. The higher the score the higher the beliefs of maintaining a healthy lifestyle.
Conditions Studied
Interventions
- BEHAVIORAL COPE-P
Study Locations (3)
Ohio
- OSU Total Health and Wellness - Columbus
- OSUWMC OB/GYN Clinic - Columbus
New York
- Jacobi Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 299 participants |
| Start Date | 2018-03-05 |
| Est. Completion | 2023-04-20 |
| Phase | NA |
What the finished NCT03416010 record still lists
NCT03416010 is an interventional study that assigns participants to a tested intervention. The registered 299 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (62% lower).
The record links to 6 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which COPE-P is the first listed.
NCT03416010 reports a single indexed study location in Ohio, New York.
Frequently Asked Questions
What is clinical trial NCT03416010 about?
NCT03416010 is a clinical study titled "Healthy Lifestyle Intervention for High-Risk Minority Pregnant Women". The overall purpose of this application is to evaluate the efficacy of an intervention designed to decrease health disparities in pregnant, emotionally distressed, minority women. This randomized controlled trial will test a six session (spaced over 18 weeks) cognitive behavioral skills building (CB...
What is the current status of trial NCT03416010?
This trial is currently completed. It is a NA study. The enrollment target is 299 participants. The study started on 2018-03-05. Estimated completion is 2023-04-20.
What conditions does trial NCT03416010 study?
This clinical trial studies the following conditions: Depression, Anxiety, Postpartum Depression, Nutritional Deficiency, Emotional Disturbances.
What interventions are being tested in trial NCT03416010?
The interventions under investigation include: COPE-P (BEHAVIORAL).
Who is sponsoring clinical trial NCT03416010?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03416010 being conducted?
This trial has 3 study locations across New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03416010's enrollment target sits among peer trials
299 148th of 679 higher than 531 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy